
|Articles|December 1, 2015
- Applied Clinical Trials-05-01-2013
- Volume 22
- Issue 5
Applied Clinical Trials Digital Edition - May 2013
Subject Recruitment: The Ideas Initiative Trial Design: Early Phase CNS Drug Liabilities; Improving Enrollment Forecasts Also in this issue: Update on Europe's Clinical Trial Rules Debate Public Perception of Clinical Research Clinical Trial Barriers
Advertisement
Articles in this issue
over 12 years ago
The IDEAS Initiativeover 12 years ago
Sponsors and Service Providers Share Their Experiencesover 12 years ago
Optimizing Efficiencyover 12 years ago
Principal Investigators Take the Lead FDA-Regulated Studiesover 12 years ago
Improving Clinical Trial Enrollment Forecasts Using SORMover 12 years ago
Breaking Down Clinical Barriersover 12 years ago
ACT Coverover 12 years ago
CNS Drug Liabilities in Early Phase Clinical TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
5






.png)



.png)



.png)
.png)
